Stop the spread! Could diagnostic antigen tests help control COVID-19 transmission in workplaces?
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
The findings are presented in a new joint technical report, which includes a survey of EU-OSHA’s focal points on the current use of rapid antigen tests in a workplace context in the EU/EEA. It builds on the body of knowledge regarding the use of rapid antigen tests provided in ECDC reports.
The report shows that rapid antigen testing can help reduce the spread of the virus in high-risk indoor workplaces. However, the report stresses that testing cannot replace other safety and health measures and should be used to complement them.
It also highlights the importance of careful planning and involving employers, workers, occupational safety and health authorities, public health authorities and occupational health services in the design of a testing strategy for the workplace before implementation.
Read the report to find out more
Infographic: rapid antigen tests for SARS-CoV-2 in the workplace
Joint ECDC - EU-OSHA infographic on the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.Read more
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update
26 Oct 2021 - This document is the first update of the technical report ‘Options for the use of rapid antigen detection tests (RADTs) for COVID-19 in the EU/EEA’. It is intended to facilitate further discussions between Member States on the settings and purpose for which it is appropriate to use RADTs and summarises key considerations for their implementation. Reaching an agreement on settings and performance criteria will be critical for the success of EU/EEA-wide surveillance purposes and for measures related to cross-border travel.
Considerations on the use of self-tests for COVID-19 in the EU/EEA
17 Mar 2021 - This document outlines the public health considerations for the use of self-tests to detect SARS-CoV-2 by public health authorities in the European Union/European Economic Area (EU/EEA). Only rapid antigen detection tests (RADTs) for self-testing for direct detection of SARS-CoV-2 virus particles in infectious individuals are considered within this document.
See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.Read more
Prevention and control of COVID-19
Information on how to protect yourself and others from COVID-19, including risk groups, vaccines, contact tracing and non-pharmaceutical interventions.Read more